Our Vision
Scopio is changing the standard of healthcare and revolutionizing first-line diagnostic testing by harnessing the power of computational photography and AI to image and analyze the morphology of cells at a scale that was never possible before, expediting access to life-saving treatments and improved patient outcomes.
Our Story
Scopio Labs was founded by two physicists and visionaries determined to push the boundaries of medicine and innovate in a way that would do some good in the world.
Early in their careers, Itai Hayut and Erez Na’aman dreamed of a collaboration. After witnessing medical practitioners in the hematology lab who still rely on analog, outdated, and labor-intensive practices using traditional microscopes and manual cell counts, they realized that with their backgrounds in physics, IT and medical device technology and the evolution of deep learning, they could use AI-powered analysis to bring microscopy and hematology into the digital age. All they needed was to find a scanner to digitize the slides, and the rest would fall into place.
But no such scanner existed, and so that’s where the Scopio story began.
The result is a series of innovations that brings high-quality data and advancements in deep learning to the practice of hematology, transforming the future of disease detection and diagnosis forever.

Leadership
Meet the Scopio Team

Roni Agami

Ofek Aizenman

Tomer Atar

Ricky Avissara

Hadas Avraham

Itay Avrahami

Niv Baehr

Tiffany Bauer

Itamar Beeri

Shaked Ben Baruch

Adir Ben-Avi

Eyal Ben-Bassat

Ilan Bleyhman

Itay Bracha

Yonatan Caimowitz

Doron Cohen

Tali Cohen

Yoav Cohen

Eliya Danino

Tomer Diament

Kaydan Giladi

Kosta Gorodetsky

Omri Gropper

Yossi Hananya

Amit Hauzer

Yossi Hayat

Mickey Iluz

Judy Keator

Ram Keidar

Yadin Kulp

Netanel Lanzkron

Dana Lazarian

Nadav Levi

Osher Levi

Ittai Madar

Amit Natan

Hila Prat

Nicki Puchalski

Dennis Ratzker

Ifat Raved

Roy Sarafov

Tal Sarid

Ben Sarusi

Chen Sasson

Ran Scheiner

Ofer Schwartz

Kim Sela

Adam Shafir

Amir Shaham

Danna Shaham

Mira Shem Tov

Hadar Shimoni

Denis Stepanov

Shahar Weil

Tal Yakir

Yaron Yaskerovitch

Bar Zelingher

Maxim Zheltobrukhov

Eran Zilkha
Press
Corporate Announcements
Feb 9, 2022: Scopio raises $50M to take a deeper look into our blood cells. The company’s ultra high quality and FDA-cleared imaging and AI analysis platforms enhance diagnostic capabilities and enable remote work
Sept 27, 2021: Scopio Labs Launches Full-Field Peripheral Blood Smear Application, Bringing End-to-End Digital Workflow to Hematology Labs to Transform Diagnostic Testing
Oct 21, 2020: FDA Clearance of Full Field PBS Application
May 13, 2020: SYNLAB Partnership
Apr. 28, 2020: Series B Funding Round
Apr. 13, 2020: CE Mark
Feb. 18, 2020: ScopioVet Launch
Notable Media Coverage
TechCrunch: Scopio aims to turn hematology into remote work with $50M C round
Jerusalem Post: Hillel’s Tech Corner: AI meets telescopy at Scopio Labs
GenomeWeb: Scopio Labs Closes $16M Round, Preps for FDA Submission of Digital Hematology System
Fortune Term Sheet: The venture capitalist at the center of the coronavirus fight
FinSMEs – The Forbes 100 NewsBlog: Scopio Labs Raises $16M in Series B Funding
CTech by Calcalist: Digital Microscope Startup Scopio Labs Raises $16 Million
Today’s Veterinary Business: Scopio Labs Launches High-Res Digital Cytology System